<i>TP53</i> loss traps AML in XPO7-NPAT nuclear transport fraud
PIKfyve inhibition creates a de novo lipogenesis dependency in MM as observed in PDAC and whether combining PIKfyve blockade with MAPK pathway inhibitors can exploit this vulnerability.
Authors
- Anna Skwarska (ORCID: https://orcid.org/0000-0002-0979-026X)
- Marina Konopleva (ORCID: https://orcid.org/0000-0002-9347-2212)
Institutions
- Albert Einstein College of Medicine (US)
Publication Details
- Journal
- Blood
- Published
- 2026-02-05
- DOI
- https://doi.org/10.1182/blood.2025032009
- Primary Topic
- Cancer-related Molecular Pathways
- Type
- article
- Field-Weighted Citation Impact
- 0.00